Results 31 to 40 of about 16,874 (230)
From heart failure and kidney dysfunction to cardiorenal syndrome: TMAO may be a bridge
The study of trimethylamine oxide (TMAO), a metabolite of gut microbiota, and heart failure and chronic kidney disease has made preliminary achievements and been summarized by many researchers, but its research in the field of cardiorenal syndrome is ...
Jialu Zhang +4 more
semanticscholar +1 more source
Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II–induced hypertension
Gut microbiota produce Trimethylamine N-oxide (TMAO) by metabolizing dietary phosphatidylcholine, choline, l-carnitine and betaine. TMAO is implicated in the pathogenesis of chronic kidney disease (CKD), diabetes, obesity and atherosclerosis.
Shan Jiang +19 more
doaj +1 more source
ETHNOPHARMACOLOGICAL RELEVANCE Treating cognitive impairment is a challenging and necessary research topic. ZeXieYin Formula (ZXYF), is a traditional herbal formula documented in the book of HuangDiNeiJing.
Jing Liu +9 more
semanticscholar +1 more source
Coronary Heart Disease and TMAO Concentrations
We congratulate Heianza et al. ([1][1]) for their important study showing the association between a 10-year change in TMAO levels and incidence of coronary heart disease. May we kindly ask the authors to provide some additional information to help put their findings into clinical perspective?
Melissa L, Amrein +4 more
openaire +2 more sources
BackgroundIntestinal inflammation and periodontitis influence the development of each other through the bidirectional relationship. As the intestinal microbiome metabolite, trimethylamine-N-oxide (TMAO) could contribute to chronic inflammation in the gut
Qiqi Wang +8 more
doaj +1 more source
Summary Background Cold exposure is one of the most important risk factors for atrial fibrillation (AF), and closely related to the poor prognosis of AF patients. However, the mechanisms underlying cold-related AF are poorly understood.
Yingchun Luo +21 more
semanticscholar +1 more source
Rui Huang,1,* Li Yan,2,* Yuhua Lei1 1Cardiovascular Disease Center, Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi Clinical College of Wuhan University, Enshi Prefecture, 445000, Hubei Province, People’s Republic of China ...
Huang R, Yan L, Lei Y
doaj
Aim: Trimethylamine N-oxide (TMAO) is a gut microbiota-derived metabolite synthesized in host organisms from specific food constituents, such as choline, carnitine and betaine. During the last decade, elevated TMAO levels have been proposed as biomarkers
Melita Videja +9 more
doaj +1 more source
Shenghong Qi,1,2 Lan Liu,1,2 Shulan He,1,2 Liqun Wang,1,2 Jiangping Li,1,2 Xian Sun1,2 1School of Public Health and Management, Ningxia Medical University, Yinchuan, Ningxia, People’s Republic of China; 2The Key Laboratory of Environmental Factors and ...
Qi S, Liu L, He S, Wang L, Li J, Sun X
doaj
Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice
Patients with chronic kidney disease (CKD) have elevated circulating levels of trimethylamine N-oxide (TMAO), a metabolite derived from gut microbes and associated with cardiovascular diseases.
Wenchao Zhang +14 more
semanticscholar +1 more source

